Yesterday
Pilot Energy to raise capital amid offshore approach
Street Talk understands the ASX-listed company, which has been suspended from the bourse since December, will on Monday launch a $5 million capital raising.
US trade player, Tanarra lob bids for Konvoy Kegs
Kegstar is said to be among a handful of parties being ushered through to the second round of the auction.
Ramsay Health Care doesn’t want to waste a Healthscope crisis
The ASX-listed hospitals group is trying to fly below the radar with Healthscope, but the door is ajar. There is blood in the water and sharks come in all varieties.
Can billionaire Anthony Hall build the next great seafood business?
The businessman made his fortune in medical imaging giant Pro Medicus. He’s snapping up abalone producers, oyster farms and fisheries for his next venture.
This Month
Oaktree Capital kicks off debt process for GenesisCare
It is understood McKnight will seek to refinance the so-called “take-back debt”, a facility that was arranged and funded by the Oaktree-led consortium of financiers.
Lew jnr bolsters retail group with Salt&Pepper deal; plots expansion
Homeware and kitchenware retailer Global Retail Brands has struck a deal to acquire Melbourne-headquartered Salt&Pepper.
Hicksons, Hunt & Hunt to merge as AI changes legal outlook
Public and private sector clients are demanding firms push down costs with AI, forcing smaller firms to look for scale to avoid unsustainable costs.
EQT Partners taps sellside adviser for $30m-a-year Nexon Asia Pacific
EQT’s Mid Market Asia fund has held a majority stake in the IT services outfit since July 2019.
Galan Lithium considers capital raising after knocking back bid
Galan is the 100 per cent owner of HMW, which – as it reminded investors at its half-year accounts – is next to the Fenix project owned by Arcadium Lithium.
TPG buys majority stake in home care biz Five Good Friends
TPG’s Joel Thickins said Five Good Friends’ mission closely aligned with the firm’s focus on backing tech-enabled businesses with the ability to improve healthcare outcomes.
PEP talk: Markdowns at The Man Shake but Fund VII set for $3b close
Sources say PEP is now valuing Cranky Health at less than its initial outlay, as the business battles high input costs and weaker demand amid cost of living pressures.
Asbestos victims want compensation assurances from James Hardie
The building materials giant will shift its primary listing to New York under a plan to merge with American group Azek.
$500m revenue family-owned pork processor kicks off sale; flyer out
BE Campbell has grown revenue 130 per cent over the past 15 years and is forecast to deliver more than $500 million revenue this financial year.
Star as we know it will be over, top execs cleaned out: Bally’s
Star Entertainment’s new controlling shareholder says there is still money to be made in gambling but the company had been badly managed for years.
Redundancies at StrongRoom AI amid fire sale; eyes on CEO
All eyes are on co-founder Max Mito, a defendant in a court case filed by EVP, who is expected to table a bid to buy back the business at cents in the dollar.
PEP bows out at Advent’s Imaging Associates
The radiology sector has offered up rich pickings for buyout firms in recent years.
Is the PE shootout for Insignia under threat? Markets think so
Insignia’s share price dropped 11 per cent in the first hour of trade on Monday to $3.50 per share, caught in the Trump tariff turmoil.
Endeavour’s Ari Mervis gets the broom out amid portfolio review
Ari Mervis is using the oldest trick in the book to placate shareholders – cutting costs, starting with staff.
How to save hospitals ‘staring into the abyss’
The debate between care providers and insurers is raging. And having heard from all sides, good luck to up-for-sale hospitals giant Healthscope.
Investor wants government review of James Hardie waiver on $14b Azek deal
Long-term James Hardie investors say the Azek deal is value destructive and were disappointed by discussions with the company’s chair Anne Lloyd on Monday.